Table 1. Cancers where CYR61 and TAZ over-expression has been previously correlated with poor outcome.

Cancer Type	CYR61 (references)	TAZ (references)
Breast	[27]	[28, 29]
Prostate	[30–32]	---
Colorectal	[33]	[34]
Gastric	[35, 36]	---
Esophageal Squamous Cell	[37, 38]	---
Esophageal Adenocarcinoma	[39]	---
Pancreas	[40, 41]	---
Hepatocellular	[42]	---
Non-Small Cell Lung	[43]---	[43],[44]
Thyroid Carcinoma	[45]	[46]ª
Renal cell carcinoma	[47]	---
Ovary	[48]	---
Glioma	[49]	[50]
Osteosarcoma	[51]	---
Epithelioid Hemangioendothelioma	---	[52]
Oral (squamous cell)	[53, 54]	---

ªPapillary